Christopher Wiley
Research Assistant Professor at Buck Institute for Research on Aging
Dr. Wiley’s research focuses on the study of aging in the context of cellular metabolism, particularly as it pertains to the process known as cellular senescence. Cellular senescence is a stress response by which cells adopt a state of permanent mitotic arrest. More than simple arrest, the senescent phenotype is complex and includes a senescence-associated secretory phenotype (SASP) that leads to secretion of multiple biologically active molecules, including proinflammatory cytokines, matrix metalloproteinases, and growth factors, that can have potent effects on the tissue microenvironment. Recently, a series of advancements have placed both senescence and the SASP at center stage with regard to variegated maladies associated with aging. Despite these advancements, senescence is still studied largely in the context of replicative exhaustion, genotoxic stress, or oncogene activation, all of which result in highly similar senescent phenotypes.
Visit website: https://www.buckinstitute.org/research/faculty/
See also: Buck Institute - Independent biomedical research institute focused on aging
Details last updated 01-Nov-2019
Christopher Wiley News
First ever non-invasive biomarker test to detect senolysis
Buck Institute - 02-Apr-2021
Detectible senescence-specific biomarker allows development of new drugs for age-related conditions
Read more...Nature Biotechnology reviews the state of play of senolytics
Nature Biotechnology - 12-Nov-2020
In August, Unity announced that its lead drug candidate had failed to beat a placebo in reducing ...
Read more...Senescent cells amplify blood clotting - now protein targets identified
Buck Institute - 24-Sep-2019
Could help tackle venous thrombosis that becomes a bigger risk with age
Read more...